Concepedia

Trina Osothprarop

TO

Statistics

Publications

7

Citations

324

H-Index

7

Active since

2011

Affiliations

Pfizer (United States)(Current)

Illumina (United States)

Trina Osothprarop is an author at Pfizer (United States) specializing in peptide therapeutics, molecular signaling, and drug discovery.

Top concepts

Publications per year

2011–2020

7

Publications

7

Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody

Jie Huang, Tetsuya Ishino, Gang Chen et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 118 citations

Characterization of chromatin accessibility with a transposome hypersensitive sites sequencing (THS-seq) assay

Brandon C. Sos, Ho-Lim Fung, Derek Gao et al. · Genome biology · 2016 · 57 citations · Full text

Improved genome sequencing using an engineered transposase

Amirali Kia, Christian Johannes Gloeckner, Trina Osothprarop et al. · BMC Biotechnology · 2017 · 42 citations · Full text

The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs

Ruth Muchekehu, Dingguo Liu, Mark Horn et al. · Translational Oncology · 2013 · 36 citations · Full text

Evolving a Thermostable Terminal Deoxynucleotidyl Transferase

Jasmine Puay Suan Chua, Maybelle Kho Go, Trina Osothprarop et al. · ACS Synthetic Biology · 2020 · 36 citations

1–5 of 7